ResMed | RMD - Market Capitalization


ResMed reported $34.45B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.99B 419M Oct/2026
Cochlear AUD 17.05B 2.6B Dec/2025
Cooper Companies USD 14.1B 1.83B Jun/2026
CSL USD 55.89B 20.42B Dec/2025
Dexcom USD 31.22B 1.34B Oct/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Fisher Paykel Healthcare NZD 21.96B 201.12M Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
Haemonetics USD 3.51B 963M Jun/2026
Idexx Laboratories USD 41.53B 3.1B Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 926M 340M Oct/2026
Intuitive Surgical USD 155.25B 11.6B Oct/2026
Medtronic USD 109.3B 2.33B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 37.19B 6.09B Oct/2026
Sigma Healthcare AUD 2.68B 2.01B Sep/2026
Steris USD 20.52B 1.16B Jun/2026
Teleflex USD 6.43B 815M Oct/2026
Thermo Fisher Scientific USD 264.64B 15.06B Oct/2026